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Abstract
Background: Osteosarcoma is the most common neoplastic disease in Scottish Deerhounds. For Deerhounds, a
2007 population-based study concluded that a single dominant genetic factor largely governed disease risk. For
Greyhounds, Rottweilers, and Irish Wolfhounds, a 2013 genome-wide association study found multiple genetic
markers in each breed, with each marker only weakly associated with the disease.
We obtained from two breeders the pedigrees, age (if alive) or age at death, and osteosarcoma status for two
families of Scottish Deerhounds, designated Cohorts K and T. A dog was considered unaffected only if it was
osteosarcoma-free and at least 8.5 years old. We analyzed the data in two ways, by assuming either a single
recessive genetic factor or a single dominant genetic factor with high penetrance.
Results: Cohort K contained 54 evaluable dogs representing 12 litters. Cohort T contained 56 evaluable dogs
representing eight litters. Osteosarcoma seemed clearly heritable in both cohorts; however, having a parent with
osteosarcoma raised a pup’s risk of developing osteosarcoma to 38% for Cohort K but 78% for Cohort T, suggesting
the possibility of different genetic risk factors in each cohort. In Cohort K, osteosarcoma inheritance fit well with a
single, recessive, autosomal risk factor, although we could not rule out the possibility of a single dominant risk
factor with incomplete penetrance. In Cohort T, inheritance could be explained well by a single, dominant,
autosomal risk factor but was inconsistent with recessive expression.
Conclusions: Inheritance of osteosarcoma in two Scottish Deerhound families could be explained well by a single
genetic risk factor residing on an autosome, consistent with a 2007 report. In one family, inheritance was consistent
with dominant expression, as previously reported. In the other family, inheritance fit better with recessive
expression, although the possibility of a dominant genetic factor influenced by one or more other genetic factors
could not be ruled out. In either case, the results suggest that there may be at least two different genetic risk
factors for osteosarcoma in Deerhounds.
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Plain English Summary
Osteosarcoma (bone cancer) is the most common cancer
in Scottish Deerhounds. For Deerhounds, a 2007 study
concluded that a single dominant genetic factor largely
governed disease risk. For Greyhounds, Rottweilers, and
Irish Wolfhounds, a 2013 study found multiple genetic
markers in each breed, with each marker only weakly
associated with the disease.
We obtained from two breeders the pedigrees, age (if
alive) or age at death, and bone cancer status for two
families of Scottish Deerhounds, designated Cohorts K
and T. A dog was considered unaffected only if it
was free of bone cancer and at least 8.5 years old.
We analyzed the data in two ways, by assuming ei-
ther a single recessive genetic factor or a single dom-
inant genetic factor.
Cohort K contained 54 evaluable dogs representing 12
litters. Cohort T contained 56 evaluable dogs represent-
ing eight litters. Bone cancer seemed clearly heritable in
both cohorts; however, having a parent with bone cancer
raised a pup’s risk of developing bone cancer itself to
38% for Cohort K but 78% for Cohort T, suggesting the
possibility of different genetic risk factors in each cohort.
In Cohort K, bone cancer inheritance fit well with a sin-
gle recessive risk factor, although we could not rule out
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the possibility of a single dominant risk factor. In Cohort
T, inheritance could be explained well by a single dom-
inant risk factor but was inconsistent with recessive
expression.
Inheritance of bone cancer in two Scottish Deerhound
families could be explained well by a single genetic risk
factor, consistent with a 2007 report. In one family,
inheritance was consistent with dominant expression,
as previously reported. In the other family, inherit-
ance fit better with recessive expression, although the
possibility of a dominant genetic factor influenced by
one or more other genetic factors could not be ruled
out. In either case, the results suggest that there may
be at least two different genetic risk factors for bone
cancer in Deerhounds.
Background
The Scottish Deerhound is a giant breed of dog originally
used to hunt Red Deer (Cervus elaphus) in Scotland.
According to the breed standard, a Deerhound “should
resemble a rough-coated Greyhound of larger size and
bone.” The standard recognizes a clear sexual dimorphism
in the breed, with males averaging 85 to 110 lb and stand-
ing 30 to 32 in. high at the withers, and bitches weighing
75 to 95 lb and standing at least 28 in. high at the withers.
The Deerhound’s balance of large size with speed and
stamina was necessary to give them some chance of
success against their quarry, as a male Red Deer averages
350 to 530 lb.
Scottish Deerhounds as a breed were first recognized
by the American Kennel Club (AKC) in 1886, but histo-
rical descriptions and illustrations go back centuries
earlier. Despite this long history, Deerhounds have
always been, and are today, a rare breed. For example, in
2008, the AKC registered only 153 new Deerhounds. By
2013 the AKC ranked the Deerhound by registrations as
166th in popularity out of 178 breeds.
For at least 50 years, the scientific community has
understood that large- and giant-breed dogs are at
greater risk of osteosarcoma than other breeds [1].
Scottish Deerhounds are no exception. In fact, osteosar-
coma is by far the most common neoplastic disease in
the breed and one of the leading causes of morbidity
and mortality. In 1996 and 2011, one of the authors of
this paper (JED) helped the Scottish Deerhound Club
of America design, conduct, and analyze the results
from health surveys sent to Deerhound owners and
breeders. The 2011 survey yielded information on 588
dogs (273 males and 315 bitches). In that population,
24 males and 35 bitches had developed osteosarcoma,
representing incidences of 9% and 11%, respectively [2].
In fact, osteosarcoma was the most commonly reported
health problem in bitches and the second most com-
monly reported health problem in males, where it was
only slightly less common than heart disease. These re-
sults are almost identical to those obtained from the
1996 survey [3].
Because osteosarcoma is often fatal, it is a leading
cause of death for Scottish Deerhounds. Of the 588 dogs
in the 2011 health survey, 306 were deceased, and the
cause of death was reported for 274 of them (122 males
and 152 bitches). Osteosarcoma was the single most
common cause of death in each sex, accounting for 22%
of the mortality in bitches and 16% of the mortality in
males [4].
Osteosarcoma risk is heritable in Scottish Deerhounds.
A 2007 study [5] used pedigrees and phenotype informa-
tion provided by owners and breeders for a population
of over 1,200 related Deerhounds to model the inherit-
ance of the osteosarcoma phenotype. The model was
then queried using variance component analysis to
estimate the heritability, and segregation analysis to infer
the presumptive mode of inheritance. Heritability was
estimated to be 0.69. Osteosarcoma risk was concluded
to be governed largely by a single major genetic variant
with dominant expression that was located on an auto-
some and increased the risk of disease 15-fold, from a
baseline risk of 5% in a Deerhound without the variant
to a risk of 75% in a Deerhound that had the variant. A
whole genome linkage approach was subsequently used
to analyze DNA samples from 60 of these dogs and map
the variant to CFA34 [6].
The conclusion that osteosarcoma risk in Deerhounds
is governed largely by a single dominant genetic variant
seems at odds with the conclusion reached about osteo-
sarcoma risk in several other large and giant breeds by
Karlsson et al. [7] from a genome-wide association study.
When these investigators compared the DNA of affected
and unaffected Greyhounds, Rottweilers, and Irish Wolf-
hounds, they identified multiple genetic variants associ-
ated with osteosarcoma risk in each breed, and none of
the 33 genetic variants accounted for a major portion of
osteosarcoma risk in any breed. Instead the associations
with osteosarcoma were relatively weak with all odds ra-
tios being <2.
The current study was undertaken to re-examine the
inheritance of osteosarcoma in Scottish Deerhounds by
conducting a traditional pedigree analysis on two
Deerhound families, each of which was relatively highly
inbred and contained many affected individuals over
many generations. We believed that such an analysis
could be used to test these conclusions from the 2007
study by Phillips et al. [5]:
1. Osteosarcoma risk in Scottish Deerhounds is
governed primarily by a single genetic variant, which
we will call a genetic risk factor in this paper,
2. The genetic risk factor lies on an autosome, and
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Pedigrees and data on age (if alive) or age at death
and osteosarcoma status for two families of Scottish
Deerhounds were obtained primarily from two long-
time North American Scottish Deerhound breeders
whose breeding programs have produced multiple affected
dogs over multiple generations. Breeder K provided infor-
mation on 91 dogs representing 15 litters, which were
designated as Cohort K. Breeder T provided information
on 104 dogs, representing 12 litters, which were desig-
nated as Cohort T.
Where necessary, we have identified an individual dog
by a code in order to keep the identities of individual
dogs confidential. Males were given three-letter codes,
and females were given four-letter codes.
Assignment of phenotype
We relied on phenotype information provided by the
breeders of each cohort and, in some instances, on infor-
mation solicited from individual dog owners. The
breeder of Cohort K is a veterinarian, and she made or
confirmed the diagnosis of osteosarcoma in affected
dogs in that cohort. In addition to one of the authors
(JED) and the breeder of Cohort K, we spoke with four
other veterinarians who are long-time Deerhound owners
and/or breeders. Together, these six veterinarians have
over 100 years of experience with the breed. Each con-
firmed that any tumor arising in a long bone of a limb of a
Scottish Deerhound is overwhelmingly likely to be osteo-
sarcoma. While this does not rule out the possibility of a
misdiagnosis in a dog in our data set, it gave us confidence
in using the phenotype information that we received.
We used 8.5 years old as the cutoff age at which we
would assign a Deerhound the unaffected phenotype;
i.e., if a dog had not developed osteosarcoma by that
age, then we considered it unaffected. This cutoff age
was is a compromise, which we selected after examining
what each pedigree would look like using cutoff ages of
6.5, 7.5, 8.5, and 9.5 years old.
On the one hand, using a cutoff age of 8.5 years old
meant that younger dogs that had not developed
osteosarcoma could not be assigned to either phenotype
(affected or unaffected). If these dogs were offspring in a
litter, then they could contribute no useful information
and so were excluded from analysis. This reduced Co-
horts K from 91 to 54 usable dogs and Cohort T from
104 to 56 usable dogs. A cutoff age of 9.5 years old
would have reduced the size of each cohort even further,
to the point where we felt there were too few individuals
for a meaningful analysis.
On the other hand, using a cutoff age of 8.5 years old
risked assigning the wrong phenotype (unaffected) to
some dogs that might go on to develop osteosarcoma.
We felt this risk was relatively small. Based on health
survey data, the average age of onset for osteosarcoma
in Scottish Deerhounds is reported to be 7.2 years in
males and 7.8 years in females [2]. One of us (JED) had
access to the data used to calculate those averages,
which are summarized in Table 1.
As the table shows, only 33% of male Deerhounds and
40% of Deerhound bitches that developed osteosarcoma
were diagnosed after they reached 8.5 years old. Based
on two separate health surveys [2, 3], the lifetime inci-
dence of osteosarcoma in Deerhounds averages about
9% in males and 11% in bitches. Consequently, the
chances of mistakenly designating a dog over 8.5 years
old as unaffected were only 3% for males (33% × 9%) and
4% for bitches (40% × 11%).
Analysis method
To analyze the pedigree and health information, we began
with the hypothesis that osteosarcoma risk in each Scottish
Deerhound cohort was governed largely by a single genetic
risk factor and then made the following assumptions:
1. The genetic risk factor was highly penetrant; i.e.,
expression of the osteosarcoma phenotype was not
greatly influenced by other genetic or environmental
Table 1 2011 Health Survey Data on Osteosarcoma in Scottish Deerhounds
Onset Age (years)a
>3.5 to 4.5 >4.5 to 5.5 >5.5 to 6.5 >6.5 to 7.5 >7.5 to 8.5 >8.5 to 9.5 >9.5 to 10.5 >10.5 to 11.5 >11.5 Total
No. diagnosed
Male 2 4 4 5 1 5 1 2 0 24
Female 0 1 5 10 5 8 3 2 1 35
Cumulative total
Male 8% 25% 42% 63% 67% 88% 92% 100% —
Female — 3% 17% 46% 60% 83% 91% 97% 100%
aThe bolded numbers represent the likelihood that an affected Deerhound would develop osteosarcoma by the cutoff age of 8.5 years old that we used for
our analysis
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factors, so that if a Deerhound inherited the risk
factor (one or two copies, depending upon whether
the risk factor is dominant or recessive) and lived
long enough, then it was very likely to develop
osteosarcoma.
2. Osteosarcoma rarely occurred in Deerhounds that
did not carry the genetic risk factor, so that if a dog
lived long enough and did not develop
osteosarcoma, then it very likely either did not carry
the genetic risk factor (if the factor was dominant)
or carried only a single copy (if the factor was
recessive).
3. Osteosarcoma in Deerhounds represented a single
phenotype; i.e., there were not multiple types of
osteosarcoma governed by different genetic risk
factors. As a corollary to this assumption, if the
genetic risk factor for osteosarcoma had dominant
expression, then the osteosarcoma phenotype would
be the same whether the affected individual was
heterozygous or homozygous.
We analyzed the information from each cohort separ-
ately, rather than assuming that the same genetic risk
factor was present in both families. This was a conserva-
tive approach. Because Scottish Deerhounds have always
been a rare breed with a small breeding population, a
good deal of close breeding has occurred. Therefore, it is
reasonable to assume that, if a single genetic factor was
governing osteosarcoma risk in Deerhounds, then it
would be the same factor throughout the breed. On the
other hand, there was no overlap (i.e., no dogs in com-
mon) in the pedigrees for the two cohorts going back at
least 7 generations, and therefore no a priori reason to
assume that the same risk factor was operating in both
cohorts.
Assuming recessive expression
When we assumed recessive expression, we used a
lower-case letter “t” (for tumor) to designate the osteo-
sarcoma risk factor and an upper case “T” to represent
the dominant normal sequence, and we also assumed
the risk factor had 100% penetrance. These premises
followed:
R1. An affected dog was always genotype t/t.
R2. An unaffected dog was always either genotype T/t
or genotype T/T. If it was genotype T/t, then it was a
silent carrier of the risk factor.
R3. If an unaffected parent produced an affected pup,
then the parent must be a silent carrier (genotype T/t).
R4. If an affected parent was crossed with an
unaffected parent, and the resulting litter contained
both affected and unaffected pups, then each
unaffected pup must be a silent carrier (genotype T/t).
Assuming dominant expression
When we assumed dominant expression, we used an
upper-case letter “C” (for cancer) to designate the osteo-
sarcoma risk factor and a lower case “c” to represent the
recessive normal sequence. Unlike when analyzing for
recessive expression, we did not assume 100% pene-
trance. This was because an initial review of the data
showed that each cohort contained at least one cross in
which two unaffected parents had produced an affected
pup, which would be unlikely if the risk factor were
dominant and 100% penetrant. (Such a result could hap-
pen if we had mistakenly designated a parent as un-
affected, but the chance of this was ≤4%, as previously
discussed).
For a population being studied, penetrance is defined
as the proportion of individuals with a particular geno-
type that also express an associated phenotype. Thus,
penetrance is impossible to calculate unless one knows
the genotype of individuals. Penetrance is said to be
incomplete when some individuals with the disease-
causing genotype fail to develop the disease. If a genetic
risk factor is dominantly expressed but has a relatively
low penetrance, then many individuals that carry the risk
factor will not develop the disease, and disease risk will
appear to be random rather than heritable [8]. Osteosar-
coma risk in our two Deerhound cohorts does not fit
that description; instead, risk appears clearly heritable in
each cohort, as was previously reported for Deerhounds
[5]. Consequently, we ruled out the possibility that
osteosarcoma risk was dominant with low penetrance
and instead analyzed for the possibility of dominant ex-
pression with high (but incomplete) penetrance. Incom-
plete penetrance can result from the influence of other
environmental or genetic factors. In the latter case, say-
ing that a risk factor has incomplete penetrance is sim-
ply another way of saying that at least one other risk
factor influences the phenotype. For a late-onset disease
like osteosarcoma, penetrance also can appear to be in-
complete because a dog with the genetic risk factor sim-
ply died of some other cause before living long enough
for osteosarcoma to arise. As already described, we re-
duced this possibility greatly (probably to ≤4%) by using
a cutoff age of 8.5 years old to designate a dog as
unaffected.
Unlike with recessive expression, a dog’s phenotype
does not reveal its full genotype when one assumes
dominant expression. Nevertheless, if we assumed a sin-
gle dominant risk factor with high (but incomplete)
penetrance, then these premises followed:
D1. Affected dogs were always either genotype C/c or C/C.
D2. Unaffected dogs could be any genotype (C/C, C/c,
or c/c). If they are C/C or C/c, then they are silent
carriers of the risk factor.
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D3. According to the definition of high penetrance,
most dogs that carried the risk factor would develop
osteosarcoma, and silent carriers would be
uncommon. In other words, most unaffected dogs
would be genotype c/c, and very few would be
genotype C/C or C/c.
D4. If a cross between two unaffected dogs produced
an affected pup, then one or both of the parents was a
silent carrier.
D5. Because silent carriers would be uncommon,
crosses between two silent carriers would be very
uncommon. Instead, when two unaffected dogs were
crossed, it would be very likely that both were
genotype c/c, unlikely (but still possible) that one was
a silent carrier (genotype C/C or C/c), and very
unlikely that both were silent carriers.
D6. For any cross where one parent was affected and
the other was not, there would be two possible
genotypes for the affected parent (C/C or C/c) and
three possible genotypes for the unaffected parent
(C/C, C/c, or c/c). In keeping with Premise D3, the
unaffected parent would be much more likely to be
genotype c/c than a silent carrier. Table 2 summarizes
the possible parental genotypes, the resulting average
pup phenotype distribution for each cross, and the
likelihood of each result.
Pedigree/phenotype/genotype diagrams
The diagrams in this paper contain only parents and
evaluable offspring; i.e., they exclude offspring that died
osteosarcoma-free before 8.5 years of age. For pheno-
type, males are represented by squares, and females are
represented by circles. An empty symbol means the dog
was unaffected (osteosarcoma-free at death), while a
filled symbol means the dog developed osteosarcoma. If
the phenotype has been inferred, rather than being
provided by the breeder, then the symbol contains a dot.
For Cohort K, we also show genotype based on
assuming a single recessive risk factor, using a lowercase
“t” for the recessive risk factor and an uppercase “T” for
the dominant normal counterpart.
Results
Cohort K (Fig. 1) contained ten litters for which the
phenotypes of both parents were known (K1-K7 and
K9-K10) and two other litters for which the phenotype
of only one parent was known (K8 and K11). Cohort T
(Fig. 2) contained six litters for which the phenotypes of
both parents were known (T1-T3, T5-T7) and two litters
for which the phenotype of only one parent was known
(T4 and T8).
A brief glance reveals that the osteosarcoma pheno-
type seems clearly heritable in both cohorts. But
differences emerge if one examines the litters that were
produced when an affected dog was bred to an
unaffected dog. Cohort K contained seven such crosses
(Litters K2-K6, K9, and K10), which resulted in the
production of 8 affected pups and 13 unaffected pups,
while Cohort T contained three such crosses (Litters
T3, T6, and T7), which resulted in the production of
18 affected pups and 5 unaffected pups. In other words,
having a parent that developed osteosarcoma raised a
pup’s risk of developing osteosarcoma to 38% in Cohort
K but to 78% in Cohort T.
Possible explanations for this difference include:
1. Osteosarcoma risk was governed by a different
single genetic risk factor in each cohort, and each
risk factor had a different mode of expression; i.e.,
the risk factor in Cohort K was recessive, while the
risk factor in Cohort T was dominant.
2. Osteosarcoma risk was governed by the same single
genetic risk factor in each cohort, but the risk factor
was more prevalent in Cohort T than Cohort K.
For a recessive risk factor, this would mean that an
unaffected dog would be much more likely to be a
heterozygous carrier than to lack the risk factor.
For a dominant risk factor, this would mean
that an affected dog would be much more
likely to be homozygous than heterozygous
for the risk factor.
3. Osteosarcoma risk was governed by multiple genetic
risk factors in each cohort, and one or more of the
risk factors had become fixed in Cohort T.
To distinguish among these possible explanations, we
analyzed the data from each cohort in two ways, first by
asking how well the results could be explained by a
single recessive risk factor and next by asking how well
the results could be explained by a single dominant risk
factor.
Table 2 Possible Pup Phenotypes for Litters Produced by an
Affected Dam and an Unaffected Sire Assuming Dominant
Expression






c/c C/c 50% 50% High
C/C 100% 0%
C/c C/c 75% 25% Low
C/C 100% 0%
CC C/c 100% 0%
C/C 100% 0%
aBased on the likelihood of the sire’s genotype
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Fig. 1 Pedigree for Cohort K, Including Genotypes Based on the Assumption of a Recessive Risk Factor. Legend: Square =male, circle = female,
filled = affected, empty = unaffected, filled with dot = phenotype unknown but inferred from the dog’s genotype
Fig. 2 Pedigree for Cohort T. Legend: Square = male, circle = female, filled = affected, empty = unaffected
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Cohort K
How well could osteosarcoma inheritance in Cohort K be
explained by assuming a single recessive risk factor (t)?
To evaluate this possibility, we examined litters produced
by two unaffected parents and litters where one parent
was affected and the other unaffected.
Both parents unaffected Litters K7 and K12 contained
only a single unaffected pup, and so were not helpful.
But Litter K1 contained two affected pups and four
unaffected pups. The sire and dam of Litter K1 (TAL
and LANG) were osteosarcoma-free when they died at
10 and 12 years of age, respectively. The production of
an affected pup by two unaffected parents is a hallmark
of recessive expression, although it does not rule out
dominant expression.
If we assumed that a single recessive genetic factor gov-
erned osteosarcoma risk in Cohort K, then the following
must be true:
 Both TAL and LANG were heterozygous carriers
(genotype T/t). This is certainly possible, as each
belonged to a litter with affected siblings.
 The osteosarcoma risk factor resides on an
autosome and not on the X chromosome, because
otherwise there could be no male heterozygous
carrier such as TAL.
 Based on Premise R3, the sires for litters K4 (OAN),
K6 (CRY), and K9 (ART) must be heterozygous
carriers (genotype T/t).
 Based on Premise R4, the 14 unaffected pups in
Litters K3-K6, K9, and K10 must be heterozygous
carriers (genotype T/t).
Based on these considerations, we assigned putative
genotypes to many of the dogs in Cohort K, as shown in
Fig. 1. There were, however, several dogs for which we
could not clearly infer a genotype.
SON sired Litter K11 by dam KELL and died at 6 years
old without developing osteosarcoma. The litter con-
tained five affected pups, so both parents carried the
osteosarcoma risk factor. KELL died osteosarcoma-free
at more than 9 years old, and so was likely a heterozy-
gous carrier. Litter K11 also contained four unaffected
pups. The approximately 1-to1 ratio of affected to un-
affected pups suggests (but does not prove) that SON
was homozygous for the risk factor, rather than a hetero-
zygous carrier, and would have developed osteosarcoma
if he had lived long enough. If that is true, then the four
unaffected pups in Litter K11 were heterozygous
carriers. We already had deduced this to be true for one
of those pups, CRY, based on the occurrence of an af-
fected pup in Litter K6 that she produced.
PEN sired Litter K10 by dam LIUM. He died
osteosarcoma-free at 12 years old, but LIUM died of
osteosarcoma when she was 10 years old. Litter K10
consisted of three unaffected pups. Two more unaffected
pups lived to be more than 8 years old (data not shown).
This suggests (but does not prove) that PEN was geno-
type T/T; i.e., a homozygous unaffected dog.
SPIG produced Litter K7 by sire CRY, which we had
deduced to be a heterozygous carrier. SPIG was
osteosarcoma-free when she died at 13 years old.
Because Litter K7 contained only a single unaffected
pup, we cannot deduce anything about SPIG’s genotype.
Sire AMP and dam MYCK produced Litter K8. AMP
died osteosarcoma-free at 6 years old and so could not
be assigned a phenotype, but dam MYCK died
osteosarcoma-free at 9.5 years old and so was considered
to be unaffected. Litter K8 contained two affected pups
and six unaffected pups, one of which was LANG, which
we have deduced to be a heterozygous carrier, based on
the occurrence of affected pups in Litter K1 that she
produced. The occurrence of affected pups in Litter K8
means that both parents carried the osteosarcoma risk
factor. Therefore, MYCK was a heterozygous carrier.
The 1-to-4 ratio of affected to unaffected offspring in
Litter K8 strongly suggests (but does not prove) that
AMP was homozygous for the risk factor, rather than a
heterozygous carrier, and would have developed osteo-
sarcoma if he had lived long enough.
One parent affected and the other unaffected Once
we had inferred potential genotypes as described, we re-
examined the six litters in which one parent was affected
and the other was deduced to be a heterozygous carrier
(Litters K2-K6 and K9). If the assumption about a single
recessive genetic risk factor were correct, then such a
cross should produce, on average, a 1-to-1 ratio of
affected to unaffected pups. The ratios of affected to
unaffected pups were 1-to-0, 2-to-1, 2-to-2, 0-to-1, 1-to-
3, and 2-to-3 for Litters K2-K6 and K9, respectively, for
an overall ratio of 8-to-10, or 0.8-to-1.
There are several factors that might account for the
slightly lower-than-expected ratio of affected to un-
affected pups in these six litters, such as:
 Chance, reflecting the relatively small sample size.
 A single pup in one of the litters was mistakenly
assigned to the unaffected phenotype. This could
happen if the pup had died osteosarcoma-free after
reaching 8.5 years old but would have developed
osteosarcoma if it had lived long enough.
 Osteosarcoma risk in Cohort K was not governed
solely by a single recessive risk factor but instead
was influenced also by an environmental factor or
other genetic factor(s).
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How well could osteosarcoma inheritance in Cohort K be
explained by assuming a single dominant risk factor (C)?
To evaluate this possibility, we examined litters pro-
duced by two unaffected parents and litters where one
parent was affected and the other unaffected.
Both parents unaffected Litter K1, produced by two
unaffected parents, contained two affected pups. While
this result is typical of a recessive risk factor, it also can
occur if a dominant risk factor has incomplete pene-
trance (<100% expression). Thus, the results for Litter
K1 do not rule out the possibility of a dominant risk
factor with relatively high penetrance.
One parent affected and the other unaffected Cohort
K contained seven litters produced by affected dams and
unaffected sires. Based on Premise D6, one would expect
the incidence of affected pups to average 75%. Table 3
shows the actual phenotypic compositions of Litters
K2-K6, K9, and K10.
The ratio of affected to unaffected pups was 8-to-13, or
0.62-to-1. This is less than the lowest ratio one would ex-
pect, which is 1-to-1 if each sire was genotype c/c and
each dam was heterozygous (genotype C/c). One possible
explanation for the lower-than-expected result is that the
risk factor was not dominant. But there are other possible
explanations, not mutually exclusive, such as:
 Chance, reflecting the relatively small sample size.
 Two pups were mistakenly assigned to the
unaffected phenotype. This could happen if they had
died osteosarcoma-free after reaching 8.5 years old
but would have developed osteosarcoma if they had
lived long enough.
 The dominant risk factor had relatively low
penetrance; i.e., osteosarcoma risk in Cohort K was
not governed solely by a single dominant risk factor
but instead was influenced also by an environmental
factor or other genetic factor(s).
Cohort T
How well could osteosarcoma inheritance in Cohort T be
explained by assuming a single recessive risk factor (t)?
As a first step, we examined the three litters in Cohort T
for which both parents were unaffected. Litter T5
contained six unaffected pups, and so was not helpful.
But Litters T1, T2, and T8 each contained affected pups.
The production of affected pups by two unaffected
parents is the hallmark of recessive expression.
If a single recessive genetic factor governed osteosar-
coma risk in Cohort T, then the following must be true:
 The five unaffected parents that produced Litters
T1, T2, and T8 (ABE, LAVE, COCA, VIK, and
DENA) were all heterozygous carriers (genotype T/t).
 The osteosarcoma risk factor resides on an
autosome and not on the X chromosome, because
otherwise there could be no male heterozygous
carriers such as ABE and VIK.
 Based on Premise R3, the sire of Litter T6 (SAM)
must be a heterozygous carrier (genotype T/t).
 Based on Premise R4, the 5 unaffected pups in
Litters T3 and T6 (including RIF, the sire of Litter
T4) must be heterozygous carriers (genotype T/t).
Once we had inferred potential genotypes as de-
scribed, we re-examined the three litters in which one
parent was affected (genotype t/t) and the other was
deduced to be a heterozygous carrier (genotype T/t). If
the assumption about a single recessive genetic risk
factor were correct, then such a cross should produce,
on average, a 1-to-1 ratio of affected to unaffected pups.
In Cohort T, the ratios of affected to unaffected pups
were 7-to-2, 7-to-3, and 4-to-0 for Litters T3, T6, and
T7, respectively, for an overall ratio of 18-to-5 or ap-
proximately 4-to-1. This is so unlikely to occur with a
recessive risk factor that it makes that hypothesis highly
unlikely for Cohort T.
How well could osteosarcoma inheritance in Cohort T be
explained by assuming a single dominant risk factor (C)?
To evaluate this possibility, we examined litters pro-
duced by two unaffected parents and litters where one
parent was affected and the other unaffected.
Both parents unaffected Cohort T contained four litters
for which both parents were unaffected. For such litters,
there were three possible genotypes for each parent (C/C,
C/c, or c/c); however, in keeping with Premise D3, each
parent was much more likely to be genotype c/c than to
be a silent carrier of genotype C/C or C/c. Because of this,
the most likely outcome of a cross between unaffected
parents would be 0% affected pups. In the unlikely event
that one parent was a silent carrier, one would expect
Table 3 Pup Phenotypes for Cohort K Litters Produced by an
Affected Dam and an Unaffected Sire
Litter Absolute phenotypes Relative phenotypes
Affected Unaffected Affected Unaffected
K2 1 0 100% 0%
K3 2 1 67% 33%
K4 2 2 50% 50%
K5 0 1 0% 100%
K6 1 3 25% 75%
K9 2 3 40% 60%
K10 0 3 0% 100%
Totals/Means 8 13 38% 62%
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either 50% or 100% affected pups, depending upon
whether the carrier parent was genotype C/c or C/C, re-
spectively. In the most unlikely event that both parents
were silent carriers, one would expect either 75% or 100%
affected pups, depending upon whether both parents were
genotype C/c or one was genotype C/C, respectively.
Litter T5 consisted of six unaffected pups, which was
the most likely outcome. But Litters T1, T2, and T8 each
contained an affected pup, which would be possible only
if each litter had at least one parent that was a silent
carrier of the dominant risk factor.
For Litters T1, T2, and T8, the ratios of affected to
unaffected pups were 1-to-3, 2-to-3, and 2-to-5, respect-
ively, for an overall ratio of 5-to-11, or 0.45-to-1. This is
less than the lowest ratio one would expect, which is 1-
to-1 if each sire was genotype c/c and each dam was
heterozygous (genotype C/c). One possible explanation
for the lower-than-expected result is that the risk factor
was not dominant. But there are other possible explana-
tions, not mutually exclusive, such as:
 Chance, reflecting the relatively small sample size.
 Three pups were mistakenly assigned to the
unaffected phenotype. This could happen if they had
died osteosarcoma-free after reaching 8.5 years old
but would have developed osteosarcoma if they had
lived long enough.
 The dominant risk factor had relatively low penetrance;
i.e., osteosarcoma risk in Cohort T was not governed
solely by a single dominant risk factor but instead was
influenced also by an environmental factor or other
genetic factor(s).
One parent affected and the other unaffected Cohort
T contained three litters produced by affected dams and
unaffected sires. Based on Premise D6, one would expect
the incidence of affected pups to average 75%. Table 4
shows the phenotypic compositions of Litters T3, T6,
and T7.
The 78% incidence of osteosarcoma is very close to
the 75% average incidence that one would expect with a
dominant risk factor that was completely penetrant.
Discussion
When it comes to analyzing inheritance patterns for
diseases that affect Scottish Deerhounds, osteosarcoma
offers some advantages but also presents some challenges.
One advantage is that the disease is relatively common.
The Scottish Deerhound Club of America conducted
health surveys in 1996 and 2011 that gathered responses
from Deerhound owners and breeders. The 2011 survey
yielded information on 588 dogs (273 males and 315
bitches), of which 24 males and 35 bitches had developed
osteosarcoma [2]. These numbers translate into incidences
of 9 and 11%, respectively.
One must be careful not to over-interpret these inci-
dence numbers. On the one hand, any survey that is not
randomly conducted tends to overestimate the incidence
of a health problem because people whose dogs have
experienced a problem are more likely to participate in
the survey than people whose dogs are healthy. The
health survey conducted by the Scottish Deerhound Club
of America did not randomly sample the Deerhound
population, and so it is possible that the true incidence of
osteosarcoma is lower than the numbers indicate.
On the other hand, because osteosarcoma arises later
in life, there is also a bias in the other direction, which
arises because the survey results included many dogs
that were still alive and too young to have had a chance
to develop osteosarcoma. Some of those dogs will go on
to develop osteosarcoma. Thus, the survey will have
tended to underestimate the true incidence of osteosar-
coma in Deerhounds.
One way to get some idea of how much bias was
introduced by including dogs that were still alive is to
analyze the data only from those Deerhounds which had
died. For the 2011 survey, the appropriate subpopula-
tions were bitches born before January 10, 1999 and
males born before July 20, 2000, because all of them had
died. These subpopulations consisted of 118 bitches and
93 males. Table 5 compares the incidence of osteosar-
coma in the entire survey population and these
subpopulations.
This analysis suggests that the bias introduced by in-
cluding data from all dogs (alive and dead) in calculating
the incidence of osteosarcoma is not trivial. However,
there also is a bias in the other direction because the sur-
vey was not randomly conducted. It is impossible to know
how these two biases—one that favors overestimation andTable 4 Pup Phenotypes for Cohort T Litters Produced by an
Affected Dam and an Unaffected Sire
Litter Absolute phenotypes Relative phenotypes
Affected Unaffected Affected Unaffected
T3 7 2 78% 22%
T6 7 3 70% 30%
T7 4 0 100% 0%
Totals/Means 18 5 78% 22%
Table 5 Incidence of Osteosarcoma in 2011 Survey
Males Bitches
Entire populationa 9% 11%
Subpopulationb 12% 16%
aEntire population is 273 males and 317 bitches
bSubpopulation is 93 males born before 7/20/2000 and 118 bitches born
before 1/10/1999, all of which have died
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other that favors underestimation—played out, but it
seems reasonable to expect that the biases canceled each
other out and that the true incidence of osteosarcoma in
Scottish Deerhounds is approximately that shown for the
entire population in Table 5.
When analyzing inheritance patterns, osteosarcoma
offers another advantage over other diseases: the affected
phenotype is easy to identify without any advanced diag-
nostic testing. Any tumor that arises in the long bone of
the limb of a middle-aged or old Scottish Deerhound
can be presumed to be osteosarcoma.
The main challenge of investigating osteosarcoma in
Scottish Deerhounds is that the disease arises late in life.
In the 2011 health survey conducted by the Scottish
Deerhound Club of America, the age of onset ranged
from 5 to 11 years old in bitches, with a mean of
7.8 years old and a median of 8 years old. In males, the
age of onset ranged from 4 to 10 years old, with a mean
of 7.2 years old and a median of 7 years old.
As a consequence of the late onset of osteosarcoma, one
has to make assumptions about how old a Deerhound
should be in order to be considered unaffected. For this
study, we chose the age of 8.5 years old as our cutoff
point, assigning the “unaffected” phenotype only to a dog
that was osteosarcoma-free and at least 8.5 years old.
For Cohort K, the inheritance of osteosarcoma could
be explained reasonably well if we assumed that risk was
governed by a single recessive genetic factor. When we
made that assumption and then deduced genotypes
where possible, there were six litters in which one parent
was affected and the other was deduced to be a hetero-
zygous carrier (Litters K2-K6 and K9). Together, those
litters contained 8 affected and 10 unaffected pups,
which is very close to the 1-to-1 ratio that one would
expect if the assumption about a single recessive genetic
risk factor were correct. In addition, a cross between
two unaffected parents in Cohort K produced a litter
with two affected pups, which is one of the hallmarks of
a recessive genetic risk factor.
On the other hand, although production of affected
offspring by two unaffected parents is typical of a reces-
sive risk factor, the same result can occur with a domin-
ant risk factor that has incomplete penetrance. Thus, the
production of affected pups by unaffected parents in Co-
hort K does not rule out the possibility of a dominant
risk factor, if that factor is incompletely penetrant. When
we assumed that osteosarcoma risk was governed by a
single dominant genetic factor and evaluated the seven
litters in Cohort K that were produced by an affected
dam and unaffected sire, we found that those litters con-
tained 8 affected and 13 unaffected pups, for a ratio of
0.62-to-1. This is less than the lowest ratio one would
expect from such crosses, which is 1-to-1 if each dam
was a heterozygous carrier. But this result does not
mean that risk is not governed by a dominant genetic
factor. Instead, the lower-than-expected ratio could be
due to chance (reflecting the relatively small sample size),
mistaken assignment of two pups to the unaffected
phenotype, or relatively low penetrance of the risk factor.
For Cohort T, the inheritance of osteosarcoma was
inconsistent with the assumption that risk is governed
by a single recessive genetic factor. If we assumed a sin-
gle recessive risk factor and then deduced genotypes
where possible, there were three litters in which one
parent was affected and the other was deduced to be a
heterozygous carrier (Litters T3, T6, and T7). Together,
those litters contained 18 affected and 5 unaffected
pups, which is very different from the 1-to-1 ratio that
one would expect if the assumption about a single reces-
sive genetic risk factor were correct. On the other hand,
the 18-to-5 ratio of affected to unaffected pups is almost
exactly what one would expect if osteosarcoma risk were
governed by a single dominant risk factor with high
penetrance.
On balance, our analysis suggests that osteosarcoma risk
in Cohort K was likely to have been governed by a single
recessive genetic factor. However, we cannot rule out the
possibility that risk was governed instead by a dominant
genetic factor with relatively low penetrance; i.e., that risk
was influenced by one or more other environmental or
genetic factors. The idea that osteosarcoma risk is influ-
enced by multiple genetic factors rather than a single
factor is more in keeping with current thinking [9].
In contrast, our analysis strongly suggests that osteosar-
coma risk in Cohort T was governed largely by a single
dominant risk factor with high penetrance, as has been
reported previously for Deerhounds [5].
We were initially surprised that our analysis suggested
a different genetic risk factor for osteosarcoma might be
operating in the two Deerhound families we studied.
The breeding population of Deerhounds has always been
small, and the application of Occam’s Razor would lead
one to expect that a single genetic risk factor was driving
osteosarcoma risk in all members of the breed.
In retrospect, our results in Deerhounds may not be
so surprising in light of a recent genome-wide associ-
ation study (GWAS) [7] that identified multiple genetic
markers for osteosarcoma in three other breeds with a
high incidence of the disease—14 in Greyhounds, 15 in
Rottweilers, and 4 in Irish Wolfhounds. The osteosarcoma
markers were different in each breed with no overlap; i.e.,
the investigators identified 33 different genetic markers
for osteosarcoma in only three breeds.
There are two reasons why a GWAS might identify a
genetic marker for osteosarcoma in one breed but not in
another: the genetic marker might really be absent in
the second breed or it might instead have become fixed
in the second breed and so have become invisible by
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GWAS. To test for fixed markers, Karlsson et al.
screened each breed for all 33 different genetic
markers. They found 8 markers that had become
fixed in one other breed and a single genetic marker
that had become fixed in both other breeds, which
was a marker on chromosome 11. This marker was
present in more affected Greyhounds (87%) than
unaffected Greyhounds (68%), but it was present in
essentially all Irish Wolfhounds (95%) and Rottweilers
(97%), regardless of osteosarcoma status.
Karlsson et al. next checked six other osteosarcoma-
prone breeds for the marker on chromosome 11. In 73
Golden Retrievers, the pattern matched that in
Rottweilers and Irish Wolfhounds, with the marker
being fixed and present in essentially all dogs,
whether affected (95%) or not (92%). In 55 Leonbergers
and 37 Great Pyrenees, the pattern matched that in
Greyhounds, with the marker being present in most
individuals but somewhat more common in affected than
unaffected dogs. In Leonbergers, the marker was present
in 77% of affected dogs and 62% of unaffected dogs, while
in Great Pyrenees, the marker was present in 78% of
affected dogs and 62% of unaffected dogs. In Mastiffs,
Great Danes, and Labrador Retrievers, the marker on
chromosome 11 was relatively uncommon. In Great
Danes, it was present at a similar low frequency in affected
and unaffected dogs, but in Mastiffs and Labrador
Retrievers, it was present in more affected dogs than
unaffected dogs.
The discovery that genetic markers for osteosar-
coma have become fixed in several breeds at high risk
for the disease suggests a possible explanation for our
results. If a single dominant genetic factor was
governing much of the osteosarcoma risk in both
Deerhound cohorts that we studied, but one or more
other genetic risk factors had become fixed in Cohort
T but not in Cohort K, then the dominant risk factor
would appear to be more highly penetrant in Cohort
T than Cohort K.
There is an important difference between the results
reported for Deerhounds in Cohort T in our study and
for a large Deerhound population in an earlier study by
Phillips et al. [5] and the results reported for Greyhounds,
Rottweilers, and Irish Wolfhounds by Karlsson et al. [7].
In Deerhounds, our analysis of Cohort T and the analysis
by Phillips et al. suggest that osteosarcoma risk is
governed largely by a single genetic variant that lies on an
autosome; i.e., a single genetic variant is rather strongly
associated with the osteosarcoma phenotype, and the
nature of the association is cause and effect. But in
Greyhounds, Rottweilers, and Irish Wolfhounds, no
single genetic variant was strongly associated with
osteosarcoma in any breed. Instead, the GWAS iden-
tified multiple genetic variants in each breed that
were only weakly associated with osteosarcoma;
specifically:
 The highest odds ratio (OR) in Irish Wolfhounds
was for SNP BICF2P1125643 (OR = 1.75), which
was present in only 4 of 28 affected dogs (14%).
 The highest OR in Rottweilers was for SNP
BICF2P411325 (OR = 1.43), which was absent in
only 27% of unaffected dogs.
 The highest ORs in Greyhounds were for SNP
BICF2P133066 and SNP TIGRP21P215623 (each
OR = 1.36). The first was present in only 12% of
affected dogs, while the latter was absent in only
11% of unaffected dogs.
Possibly Karlsson et al. did not find a SNP that was
strongly associated with osteosarcoma in any of the
breeds they studied because no single genetic variant
governs osteosarcoma risk in those breeds. We think
this is unlikely because in at least one family of Irish
Wolfhounds, osteosarcoma risk is reportedly governed
largely by a single genetic variant with an autosomal
inheritance pattern [10], as appears also to be true in
at least some Deerhound families.
In fact, the results obtained by Karlsson et al. are in
keeping with those of many other GWASs. For reasons
that are still unclear, GWASs routinely fail to identify a
genetic variant strongly associated with a disease pheno-
type [11]. There has been much speculation about why
this is so [12, 13].
The previous analysis by Phillips et al. [5] suggested
that the inheritance of osteosarcoma in Scottish
Deerhounds was governed largely by a single genetic
variant with dominant expression. We concluded the
same thing for our Cohort T. However, our analysis
suggested that osteosarcoma in Cohort K was governed
either largely by a single genetic variant with recessive
expression or by a combination of an incompletely
dominant genetic factor and at least one other genetic
or environmental factor. When we checked with the
breeders who supplied us with information on each co-
hort, we learned that many individuals in Cohort T had
also been included in the population analyzed by Phillips
et al., but that Cohort K had not been part of that popula-
tion. This may explain why our results for Cohort T
matched those of Phillips et al.
The analysis described in this paper will be followed
by genetic mapping. For both of the Deerhound families
that we studied, DNA samples from at least some of the
deceased dogs are banked in one or more repositories.
With the help of the Scottish Deerhound Club of America,
we are currently arranging for access to those sam-
ples, and also arranging to obtain DNA samples from
dogs in both families that are still alive, and from
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their descendants. Our initial intention is to screen
the samples for osteosarcoma-related genetic variants
previously identified in Deerhounds, Wolfhounds,
Greyhounds, and Rottweilers.
Conclusions
Inheritance of osteosarcoma in two Scottish Deerhound
families could be explained well by a single genetic risk
factor residing on an autosome, consistent with a previ-
ous report. In one family, inheritance was consistent
with dominant expression, as previously reported. In the
other family, inheritance fit better with recessive expres-
sion, although the possibility of a dominant genetic factor
influenced by one or more other genetic factors could not
be ruled out. In either case, the results suggest that there
may be at least two different genetic risk factors for osteo-
sarcoma in Deerhounds.
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